The Discounted Cash Flow (DCF) valuation of Resmed Inc (RMD) is 250.55 USD. With the latest stock price at 256.26 USD, the upside of Resmed Inc based on DCF is -2.2%.
Based on the latest price of 256.26 USD and our DCF valuation, Resmed Inc (RMD) is a sell. selling Resmed stocks now will result in a potential gain of 2.2%.
Range | Selected | |
WACC / Discount Rate | 7.0% - 9.7% | 8.3% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | 167.25 - 534.25 | 250.55 |
Upside | -34.7% - 108.5% | -2.2% |